首页 > 最新文献

Clinical nephrology最新文献

英文 中文
The protective powers of L-theanine against drug-induced kidney damage. 左旋茶氨酸对药物性肾损伤的保护作用
IF 1.1 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-11-28 DOI: 10.5414/CN111549
Yahya Altinkaynak, Elizaveta Burenkova, Akcan Buket
<p><strong>Background: </strong>Drug-induced kidney damage (DIKD) is a significant medical concern linked to many drugs, including nonsteroidal anti-inflammatory drugs, antibiotics, and chemotherapy agents, due to its complex pathophysiology. L-theanine, a tea leaf amino acid, is explored for its protective effects against DIKD, considering its cognitive and calming benefits.</p><p><strong>Materials and methods: </strong>In the theoretical part of the article, the role of L-theanine in combating DIKD is reviewed, highlighting its ability to mitigate oxidative stress and inflammation by neutralizing reactive oxygen species, enhancing antioxidant defenses, and modulating anti-inflammatory pathways. L-theanine's influence on cell signaling and its synergy with other nephroprotective agents are discussed. The practical part describes an experimental study using a murine model, where 60 male C57BL/6 mice were divided into four groups: a control group, a nephrotoxic group treated with cisplatin, and two treatment groups that received L-theanine either before or after cisplatin administration. Serum biomarkers (creatinine and blood urea nitrogen (BUN)), histopathological kidney damage scores, and oxidative stress markers (malondialdehyde (MDA) and superoxide dismutase (SOD)) were measured.</p><p><strong>Results: </strong>Evidence from the murine study indicates that L-theanine protects against DIKD through antioxidative, anti-inflammatory, and anti-apoptotic mechanisms, potentially enhancing its synergy with other nephroprotective agents. In the nephrotoxic group (N), serum creatinine and BUN levels were significantly elevated, while pre-treatment with L-theanine (LTP) reduced these levels to 1.2 ± 0.3 mg/dL and 34 ± 4 mg/dL, respectively. Histopathological analysis revealed severe tubular necrosis in the N group (score: 3.8 ± 0.3), which was significantly reduced in the LTP group (1.6 ± 0.4). Oxidative stress markers, such as MDA, were markedly lowered in the LTP group compared to the N group, with corresponding increases in SOD activity, indicating enhanced antioxidant defense. These findings underscore L-theanine's potential in preserving renal health amidst pharmacotherapy-induced toxicity.</p><p><strong>Conclusion: </strong>L-theanine emerges as a promising nephroprotective agent, particularly in the context of increasing incidence of DIKD and the associated challenges in clinical management. The practical findings from this study in a murine model provide compelling evidence that L-theanine significantly reduces serum biomarkers of renal injury, attenuates tubular necrosis, and mitigates oxidative stress, with pronounced effects observed when administered as a pre-treatment. While these results are promising, the predominance of preclinical data underscores the need for rigorous human studies to validate L-theanine's efficacy and safety in the prevention of drug-related renal injuries. Such research is crucial for advancing renal protection strate
背景:药物引起的肾损伤(DIKD)是与许多药物(包括非甾体抗炎药、抗生素和化疗药)相关的一个重大医学问题,因为其病理生理学非常复杂。L-茶氨酸是一种茶叶氨基酸,考虑到其在认知和镇静方面的益处,我们正在探索它对 DIKD 的保护作用:文章的理论部分回顾了左旋茶氨酸在抗击 DIKD 中的作用,强调了它通过中和活性氧、增强抗氧化防御和调节抗炎途径来减轻氧化应激和炎症的能力。报告还讨论了左旋茶氨酸对细胞信号传导的影响及其与其他肾保护剂的协同作用。实际操作部分介绍了一项利用小鼠模型进行的实验研究,该研究将 60 只雄性 C57BL/6 小鼠分为四组:对照组、接受顺铂治疗的肾毒性组,以及在顺铂给药前或给药后接受左旋茶氨酸治疗的两组。研究测量了血清生物标志物(肌酐和血尿素氮(BUN))、组织病理学肾损伤评分以及氧化应激标志物(丙二醛(MDA)和超氧化物歧化酶(SOD)):结果:小鼠研究的证据表明,左旋茶氨酸通过抗氧化、抗炎和抗细胞凋亡机制保护肾脏免受DIKD的侵害,并有可能增强其与其他肾脏保护剂的协同作用。在肾毒性组(N)中,血清肌酐和尿素氮水平显著升高,而使用左旋茶氨酸(LTP)预处理后,血清肌酐和尿素氮水平分别降至 1.2 ± 0.3 mg/dL 和 34 ± 4 mg/dL。组织病理学分析显示,N 组的肾小管坏死程度严重(评分:3.8 ± 0.3),而 LTP 组的肾小管坏死程度明显降低(1.6 ± 0.4)。与 N 组相比,LTP 组的氧化应激标志物(如 MDA)明显降低,SOD 活性相应增加,表明抗氧化防御能力增强。这些发现强调了左旋茶氨酸在药物治疗引起的毒性中保护肾脏健康的潜力:结论:L-茶氨酸是一种很有前景的肾脏保护剂,尤其是在 DIKD 的发病率不断上升、临床治疗面临挑战的情况下。本研究在小鼠模型中的实际发现提供了令人信服的证据,证明左旋茶氨酸可显著降低肾损伤的血清生物标志物、减轻肾小管坏死和氧化应激,在作为预处理给药时效果明显。虽然这些结果很有希望,但临床前数据占主导地位,这突出表明需要进行严格的人体研究,以验证 L -茶氨酸在预防药物相关肾损伤方面的有效性和安全性。此类研究对于推进药物治疗中的肾脏保护策略至关重要。
{"title":"The protective powers of L-theanine against drug-induced kidney damage.","authors":"Yahya Altinkaynak, Elizaveta Burenkova, Akcan Buket","doi":"10.5414/CN111549","DOIUrl":"10.5414/CN111549","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Drug-induced kidney damage (DIKD) is a significant medical concern linked to many drugs, including nonsteroidal anti-inflammatory drugs, antibiotics, and chemotherapy agents, due to its complex pathophysiology. L-theanine, a tea leaf amino acid, is explored for its protective effects against DIKD, considering its cognitive and calming benefits.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Materials and methods: &lt;/strong&gt;In the theoretical part of the article, the role of L-theanine in combating DIKD is reviewed, highlighting its ability to mitigate oxidative stress and inflammation by neutralizing reactive oxygen species, enhancing antioxidant defenses, and modulating anti-inflammatory pathways. L-theanine's influence on cell signaling and its synergy with other nephroprotective agents are discussed. The practical part describes an experimental study using a murine model, where 60 male C57BL/6 mice were divided into four groups: a control group, a nephrotoxic group treated with cisplatin, and two treatment groups that received L-theanine either before or after cisplatin administration. Serum biomarkers (creatinine and blood urea nitrogen (BUN)), histopathological kidney damage scores, and oxidative stress markers (malondialdehyde (MDA) and superoxide dismutase (SOD)) were measured.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Evidence from the murine study indicates that L-theanine protects against DIKD through antioxidative, anti-inflammatory, and anti-apoptotic mechanisms, potentially enhancing its synergy with other nephroprotective agents. In the nephrotoxic group (N), serum creatinine and BUN levels were significantly elevated, while pre-treatment with L-theanine (LTP) reduced these levels to 1.2 ± 0.3 mg/dL and 34 ± 4 mg/dL, respectively. Histopathological analysis revealed severe tubular necrosis in the N group (score: 3.8 ± 0.3), which was significantly reduced in the LTP group (1.6 ± 0.4). Oxidative stress markers, such as MDA, were markedly lowered in the LTP group compared to the N group, with corresponding increases in SOD activity, indicating enhanced antioxidant defense. These findings underscore L-theanine's potential in preserving renal health amidst pharmacotherapy-induced toxicity.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;L-theanine emerges as a promising nephroprotective agent, particularly in the context of increasing incidence of DIKD and the associated challenges in clinical management. The practical findings from this study in a murine model provide compelling evidence that L-theanine significantly reduces serum biomarkers of renal injury, attenuates tubular necrosis, and mitigates oxidative stress, with pronounced effects observed when administered as a pre-treatment. While these results are promising, the predominance of preclinical data underscores the need for rigorous human studies to validate L-theanine's efficacy and safety in the prevention of drug-related renal injuries. Such research is crucial for advancing renal protection strate","PeriodicalId":10396,"journal":{"name":"Clinical nephrology","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2024-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142738560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predicting AKI in critical patients: An interpretable model based on albumin and fluid balance. 预测危重病人的 AKI:基于白蛋白和体液平衡的可解释模型。
IF 1.1 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-11-28 DOI: 10.5414/CN111510
Yifan Xu, Zengyu Zhang, Bai Xu, Lan Sun, Lei Zhong, Yuqi Chen, Siyu Tang, Yan Qu, Xianghong Yang

Background: Acute kidney injury (AKI) is a clinically complex syndrome with a high incidence and mortality rate in the intensive care unit (ICU). Early identification of high-risk patients and timely intervention are crucial.

Objective: A local database was used to construct a model that predicts the incidence of AKI in ICU patients within 48 hours.

Materials and methods: We conducted a study involving 9,628 critically ill patients at Zhejiang Provincial People's Hospital and divided the cohort into derivation and validation groups. We collected and analyzed demographic data, vital signs, laboratory tests, medications, clinical interventions, and other information for all patients, resulting in a total of 232 variables. Six different machine learning algorithms were employed to construct models, and the optimal model was selected and validated.

Results: A total of 2,441 patients were included, of whom 1,138 (46.62%) met the AKI criteria. A model was derived that included 16 variables such as albumin transfusion, fluid balance, diastolic blood pressure (DBP), partial pressure of oxygen (PO2), blood glucose (GLU), platelet (PLT), baseline serum creatinine (bSCr), serum sodium, age, epinephrine, proton pump inhibitor (PPI), intra-abdominal infection, anemia, diabetes, glycerin fructose, and nutritional pathway. The area under the receiver operating characteristic curve (AUC) was 0.822. Subgroup analysis revealed the impact of blood pressure fluctuations on AKI. Additionally, the study demonstrated a bidirectional effect of albumin and fluid balance on AKI.

Conclusion: This model is highly accurate and may facilitate the early diagnosis of and interventions for AKI.

背景:急性肾损伤(AKI)是一种临床复杂的综合征,在重症监护病房(ICU)中发病率和死亡率都很高。早期识别高危患者并及时干预至关重要:利用本地数据库构建了一个模型,该模型可预测重症监护室患者 48 小时内 AKI 的发生率:我们对浙江省人民医院的 9628 名重症患者进行了研究,并将队列分为推导组和验证组。我们收集并分析了所有患者的人口统计学数据、生命体征、实验室检查、用药、临床干预和其他信息,共得出 232 个变量。我们采用了六种不同的机器学习算法来构建模型,并选择和验证了最佳模型:共纳入 2,441 名患者,其中 1,138 人(46.62%)符合 AKI 标准。得出的模型包括 16 个变量,如白蛋白输注、体液平衡、舒张压(DBP)、氧分压(PO2)、血糖(GLU)、血小板(PLT)、基线血清肌酐(bSCr)、血清钠、年龄、肾上腺素、质子泵抑制剂(PPI)、腹腔内感染、贫血、糖尿病、甘油果糖和营养途径。接收者操作特征曲线下面积(AUC)为 0.822。亚组分析显示了血压波动对 AKI 的影响。此外,该研究还证明了白蛋白和液体平衡对 AKI 的双向影响:结论:该模型非常准确,有助于对 AKI 进行早期诊断和干预。
{"title":"Predicting AKI in critical patients: An interpretable model based on albumin and fluid balance.","authors":"Yifan Xu, Zengyu Zhang, Bai Xu, Lan Sun, Lei Zhong, Yuqi Chen, Siyu Tang, Yan Qu, Xianghong Yang","doi":"10.5414/CN111510","DOIUrl":"10.5414/CN111510","url":null,"abstract":"<p><strong>Background: </strong>Acute kidney injury (AKI) is a clinically complex syndrome with a high incidence and mortality rate in the intensive care unit (ICU). Early identification of high-risk patients and timely intervention are crucial.</p><p><strong>Objective: </strong>A local database was used to construct a model that predicts the incidence of AKI in ICU patients within 48 hours.</p><p><strong>Materials and methods: </strong>We conducted a study involving 9,628 critically ill patients at Zhejiang Provincial People's Hospital and divided the cohort into derivation and validation groups. We collected and analyzed demographic data, vital signs, laboratory tests, medications, clinical interventions, and other information for all patients, resulting in a total of 232 variables. Six different machine learning algorithms were employed to construct models, and the optimal model was selected and validated.</p><p><strong>Results: </strong>A total of 2,441 patients were included, of whom 1,138 (46.62%) met the AKI criteria. A model was derived that included 16 variables such as albumin transfusion, fluid balance, diastolic blood pressure (DBP), partial pressure of oxygen (PO<sub>2</sub>), blood glucose (GLU), platelet (PLT), baseline serum creatinine (bSCr), serum sodium, age, epinephrine, proton pump inhibitor (PPI), intra-abdominal infection, anemia, diabetes, glycerin fructose, and nutritional pathway. The area under the receiver operating characteristic curve (AUC) was 0.822. Subgroup analysis revealed the impact of blood pressure fluctuations on AKI. Additionally, the study demonstrated a bidirectional effect of albumin and fluid balance on AKI.</p><p><strong>Conclusion: </strong>This model is highly accurate and may facilitate the early diagnosis of and interventions for AKI.</p>","PeriodicalId":10396,"journal":{"name":"Clinical nephrology","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2024-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142738591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical factors associated with hospital mortality in critically ill adult COVID-19 patients with AKI requiring CRRT: A multicenter study. 需要进行 CRRT 的 COVID-19 重症成人 AKI 患者住院死亡率的相关临床因素:一项多中心研究。
IF 1.1 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-11-20 DOI: 10.5414/CN111404
Augusto Cama-Olivares, Ashutosh Tamhane, Victor Ortiz-Soriano, Douglas Farrell, Huei Hsun Wen, Tomonori Takeuchi, Patel Devansh, Francesco Galasso, Jin Chen, Lili Chan, Ashita J Tolwani, Girish N Nadkarni, Javier A Neyra

Background: Acute kidney injury (AKI) is a common complication of critically ill COVID-19 patients which is associated with adverse outcomes. We examined clinical factors associated with hospital mortality in critically ill adult COVID-19 patients with AKI who required continuous renal replacement therapy (CRRT).

Materials and methods: We conducted a multicenter retrospective cohort study including data from two large academic medical centers. Adult (age ≥ 18 years) patients with AKI and requiring CRRT admitted from March 2020 to April 2021 were included in the study. Patients with end-stage kidney disease or renal transplantation were excluded. Multivariable Poisson regression analyses were used to identify clinical predictors of hospital mortality.

Results: A total of 178 patients were included. Patients were predominantly men (68.2%), 13.1% were Black, and 57.9% White. Median hospital and ICU length of stay were 20 days and 14 days, respectively. Mechanical ventilation and extracorporeal membrane oxygenation were utilized in 97.2% and 17.4% of patients, respectively. Overall, 130 (73.0%) patients died in the hospital (mortality rate of 2.7 per 100 person-days). In multivariable analyses, SOFA score ≥ 12 at ICU admission (MRRadj = 1.88; 95% CI 1.17 - 3.01) was associated with increased risk of mortality, while Black race (MRRadj = 0.56; 95% CI 0.31 - 1.01) was associated with a decreased risk of mortality.

Conclusion: More than two-thirds of critically ill adult COVID-19 patients with AKI requiring CRRT died during hospitalization. SOFA score ≥ 12 at ICU admission was an independent predictor of hospital mortality, and Black patients had a lower risk of mortality.

背景:急性肾损伤(AKI)是COVID-19重症患者的常见并发症,与不良预后相关。我们研究了与需要持续肾脏替代治疗(CRRT)的急性肾损伤(AKI)重症成人 COVID-19 患者住院死亡率相关的临床因素:我们进行了一项多中心回顾性队列研究,包括来自两个大型学术医疗中心的数据。研究纳入了 2020 年 3 月至 2021 年 4 月期间收治的需要 CRRT 的 AKI 成人患者(年龄≥18 岁)。不包括终末期肾病或肾移植患者。采用多变量泊松回归分析确定住院死亡率的临床预测因素:共纳入 178 名患者。患者主要为男性(68.2%),13.1%为黑人,57.9%为白人。中位住院时间和重症监护室住院时间分别为 20 天和 14 天。分别有 97.2% 和 17.4% 的患者使用了机械通气和体外膜氧合。共有 130 名(73.0%)患者在住院期间死亡(死亡率为每 100 人天 2.7 例)。在多变量分析中,ICU入院时SOFA评分≥12分(MRRadj = 1.88; 95% CI 1.17 - 3.01)与死亡风险增加有关,而黑人种族(MRRadj = 0.56; 95% CI 0.31 - 1.01)与死亡风险降低有关:结论:超过三分之二的 COVID-19 重症成人 AKI 患者在住院期间死亡,这些患者需要接受 CRRT 治疗。入ICU时SOFA评分≥12分是住院死亡率的独立预测因素,黑人患者的死亡风险较低。
{"title":"Clinical factors associated with hospital mortality in critically ill adult COVID-19 patients with AKI requiring CRRT: A multicenter study.","authors":"Augusto Cama-Olivares, Ashutosh Tamhane, Victor Ortiz-Soriano, Douglas Farrell, Huei Hsun Wen, Tomonori Takeuchi, Patel Devansh, Francesco Galasso, Jin Chen, Lili Chan, Ashita J Tolwani, Girish N Nadkarni, Javier A Neyra","doi":"10.5414/CN111404","DOIUrl":"10.5414/CN111404","url":null,"abstract":"<p><strong>Background: </strong>Acute kidney injury (AKI) is a common complication of critically ill COVID-19 patients which is associated with adverse outcomes. We examined clinical factors associated with hospital mortality in critically ill adult COVID-19 patients with AKI who required continuous renal replacement therapy (CRRT).</p><p><strong>Materials and methods: </strong>We conducted a multicenter retrospective cohort study including data from two large academic medical centers. Adult (age ≥ 18 years) patients with AKI and requiring CRRT admitted from March 2020 to April 2021 were included in the study. Patients with end-stage kidney disease or renal transplantation were excluded. Multivariable Poisson regression analyses were used to identify clinical predictors of hospital mortality.</p><p><strong>Results: </strong>A total of 178 patients were included. Patients were predominantly men (68.2%), 13.1% were Black, and 57.9% White. Median hospital and ICU length of stay were 20 days and 14 days, respectively. Mechanical ventilation and extracorporeal membrane oxygenation were utilized in 97.2% and 17.4% of patients, respectively. Overall, 130 (73.0%) patients died in the hospital (mortality rate of 2.7 per 100 person-days). In multivariable analyses, SOFA score ≥ 12 at ICU admission (MRRadj = 1.88; 95% CI 1.17 - 3.01) was associated with increased risk of mortality, while Black race (MRRadj = 0.56; 95% CI 0.31 - 1.01) was associated with a decreased risk of mortality.</p><p><strong>Conclusion: </strong>More than two-thirds of critically ill adult COVID-19 patients with AKI requiring CRRT died during hospitalization. SOFA score ≥ 12 at ICU admission was an independent predictor of hospital mortality, and Black patients had a lower risk of mortality.</p>","PeriodicalId":10396,"journal":{"name":"Clinical nephrology","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2024-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142674988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Peritoneal dialysis-related complication: Can diagnostic accuracy be achieved at low iodinated contrast media dose using dual-layer spectral detector CT? 腹膜透析相关并发症:使用双层光谱探测器 CT,能否在低碘造影剂剂量下实现诊断准确性?
IF 1.1 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-11-20 DOI: 10.5414/CN111478
Jiao Bai, Yu Zhang, Fang Wang, Linwang Gan, Dongmei Zhao, Jian Shu

Introduction: Computed tomography peritoneography (CTp) is pivotal for evaluating peritoneal dialysis (PD)-related complications, yet it comes with drawbacks, specifically exposure to iodinated contrast media (ICM). This study aimed to explore the feasibility of reducing ICM dosage utilizing spectral detector CT (SDCT).

Materials and methods: 35 rabbits were strategically divided into 7 groups (A - G) according to the ICM concentration ratio in the injection protocol, with respective doses of 10, 15, 20, 25, 30, 40, and 50 mL/2L. The CTp injection protocol involved a 300-mL mixture of non-ionic ICM omnipaque (350 mgI/mL) and peritoneal dialysate (1.5% lactate, 2 L), followed by scans using dual-layer SDCT. Virtual monoenergetic images (VMIs) at 4 distinct energy levels (40 - 70 keV, in 10-keV steps), iodine maps (IMs), and effective atomic number (Zeff) maps were subsequently reconstructed. Both quantitative and qualitative image assessments were conducted, and the parameters from these analyses were compared across images from groups A - G and traditional 50 mL/2L 120-kVp images. In post-determination of the optimal concentration and reconstructions, we illustrated their applications in patients with suspected PD-related complications.

Results: The quantitative image quality (IQ) of 15 mL/2L VMIs at 40 keV surpassed that of the 50 mL/2L 120-kVp images (p < 0.05). Furthermore, the diagnostic performance utilizing 15 mL/2L VMIs40 keV, when combined with IMs and Zeff maps, was found to be optimal.

Conclusion: The employment of SDCT in CTp allows for a substantial reduction in the ICM dose by 70%, compared to the benchmark concentration of 50 mL/2L, without compromising diagnostic precision.

简介:计算机断层扫描腹膜成像(CTp)是评估腹膜透析(PD)相关并发症的关键,但它也有缺点,特别是暴露于碘化造影剂(ICM)。本研究旨在探索利用光谱探测器 CT(SDCT)减少 ICM 剂量的可行性。材料和方法:根据注射方案中的 ICM 浓度比,将 35 只兔子策略性地分为 7 组(A - G),剂量分别为 10、15、20、25、30、40 和 50 mL/2L。CTp 注射方案包括 300 毫升的非离子 ICM omnipaque(350 毫克 I/毫升)和腹膜透析液(1.5% 乳酸盐,2 升)混合物,然后使用双层 SDCT 扫描。随后重建了 4 个不同能级(40 - 70 千伏,以 10 千伏为单位)的虚拟单能级图像 (VMI)、碘图 (IM) 和有效原子序数 (Zeff) 图。对图像进行了定量和定性评估,并将这些分析得出的参数与 A - G 组图像和传统的 50 mL/2L 120 kVp 图像进行了比较。在确定最佳浓度和重建后,我们说明了它们在疑似腹膜透析相关并发症患者中的应用:结果:15 mL/2L VMI 在 40 keV 下的定量图像质量(IQ)超过了 50 mL/2L 120 kVp 图像(p < 0.05)。此外,当 15 mL/2L VMIs40 keV 与 IMs 和 Zeff 地图结合使用时,诊断性能达到最佳:结论:与 50 mL/2L 的基准浓度相比,在 CTp 中使用 SDCT 可将 ICM 剂量大幅减少 70%,而不会影响诊断精度。
{"title":"Peritoneal dialysis-related complication: Can diagnostic accuracy be achieved at low iodinated contrast media dose using dual-layer spectral detector CT?","authors":"Jiao Bai, Yu Zhang, Fang Wang, Linwang Gan, Dongmei Zhao, Jian Shu","doi":"10.5414/CN111478","DOIUrl":"10.5414/CN111478","url":null,"abstract":"<p><strong>Introduction: </strong>Computed tomography peritoneography (CTp) is pivotal for evaluating peritoneal dialysis (PD)-related complications, yet it comes with drawbacks, specifically exposure to iodinated contrast media (ICM). This study aimed to explore the feasibility of reducing ICM dosage utilizing spectral detector CT (SDCT).</p><p><strong>Materials and methods: </strong>35 rabbits were strategically divided into 7 groups (A - G) according to the ICM concentration ratio in the injection protocol, with respective doses of 10, 15, 20, 25, 30, 40, and 50 mL/2L. The CTp injection protocol involved a 300-mL mixture of non-ionic ICM omnipaque (350 mgI/mL) and peritoneal dialysate (1.5% lactate, 2 L), followed by scans using dual-layer SDCT. Virtual monoenergetic images (VMIs) at 4 distinct energy levels (40 - 70 keV, in 10-keV steps), iodine maps (IMs), and effective atomic number (Zeff) maps were subsequently reconstructed. Both quantitative and qualitative image assessments were conducted, and the parameters from these analyses were compared across images from groups A - G and traditional 50 mL/2L 120-kVp images. In post-determination of the optimal concentration and reconstructions, we illustrated their applications in patients with suspected PD-related complications.</p><p><strong>Results: </strong>The quantitative image quality (IQ) of 15 mL/2L VMIs at 40 keV surpassed that of the 50 mL/2L 120-kVp images (p < 0.05). Furthermore, the diagnostic performance utilizing 15 mL/2L VMIs40 keV, when combined with IMs and Zeff maps, was found to be optimal.</p><p><strong>Conclusion: </strong>The employment of SDCT in CTp allows for a substantial reduction in the ICM dose by 70%, compared to the benchmark concentration of 50 mL/2L, without compromising diagnostic precision.</p>","PeriodicalId":10396,"journal":{"name":"Clinical nephrology","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2024-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142674978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of artificial intelligence and machine learning for risk stratification acute kidney injury among hematopoietic stem cell transplantation patients: PCRRT ICONIC AI Initiative Group Meeting Proceedings. 应用人工智能和机器学习对造血干细胞移植患者的急性肾损伤进行风险分层:PCRRT ICONIC人工智能倡议小组会议论文集。
IF 1.1 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-11-15 DOI: 10.5414/CN111421
Rupesh Raina, Kush Doshi, Pushan Aggarwal, Parker Kim, Jonathan Sasse, Sidharth Sethi, Carolyn Abitbol, Rolla Abu-Arja, Kianoush Kashani

Acute kidney injury (AKI) is a frequent, severe complication of hematopoietic stem cell transplantation (HSCT) and is associated with an increased risk of morbidity and mortality. Recent advances in artificial intelligence (AI) and machine learning (ML) have showcased their proficiency in predicting AKI, projecting disease progression, and accurately identifying underlying etiologies. This review examines the central aspects of AKI post-HSCT, veno-occlusive disease (VOD) in HSCT recipients, discusses present-day applications of artificial intelligence in AKI, and introduces a proposed ML framework for the early detection of AKI risk.

急性肾损伤(AKI)是造血干细胞移植(HSCT)中一种常见的严重并发症,与发病率和死亡率的增加有关。人工智能(AI)和机器学习(ML)的最新进展展示了它们在预测 AKI、预测疾病进展和准确识别潜在病因方面的能力。这篇综述探讨了造血干细胞移植后 AKI 的核心问题、造血干细胞移植受者的静脉闭塞性疾病 (VOD),讨论了人工智能在 AKI 中的最新应用,并介绍了用于早期检测 AKI 风险的拟议 ML 框架。
{"title":"Application of artificial intelligence and machine learning for risk stratification acute kidney injury among hematopoietic stem cell transplantation patients: PCRRT ICONIC AI Initiative Group Meeting Proceedings.","authors":"Rupesh Raina, Kush Doshi, Pushan Aggarwal, Parker Kim, Jonathan Sasse, Sidharth Sethi, Carolyn Abitbol, Rolla Abu-Arja, Kianoush Kashani","doi":"10.5414/CN111421","DOIUrl":"10.5414/CN111421","url":null,"abstract":"<p><p>Acute kidney injury (AKI) is a frequent, severe complication of hematopoietic stem cell transplantation (HSCT) and is associated with an increased risk of morbidity and mortality. Recent advances in artificial intelligence (AI) and machine learning (ML) have showcased their proficiency in predicting AKI, projecting disease progression, and accurately identifying underlying etiologies. This review examines the central aspects of AKI post-HSCT, veno-occlusive disease (VOD) in HSCT recipients, discusses present-day applications of artificial intelligence in AKI, and introduces a proposed ML framework for the early detection of AKI risk.</p>","PeriodicalId":10396,"journal":{"name":"Clinical nephrology","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142616145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correlation between indole-3-acetic acid and left ventricular hypertrophy in hemodialysis patients. 血液透析患者吲哚-3-乙酸与左心室肥厚之间的相关性。
IF 1.1 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-11-15 DOI: 10.5414/CN111299
Zhihua Lu, Wei Su, Ping Fan, Jiangtao Zhu, Cheng Chen

Background: Among hemodialysis patients, left ventricular hypertrophy (LVH) is a prevalent cardiac abnormality. The uremic toxin indole-3-acetic acid (IAA) is elevated in uremia patients, but the connection between IAA and LVH in individuals undergoing hemodialysis remains uncertain. Hence, the objective of this research was to examine the correlation between blood IAA levels and LVH in individuals undergoing hemodialysis.

Materials and methods: In total, 205 individuals undergoing hemodialysis were chosen and categorized into two groups, with (143 patients) and without LVH (62 patients). Patient clinical data were collected, and serum creatinine, calcium, phosphorus, hemoglobin, and IAA levels were measured.

Results: Compared to the non-LVH group, the LVH group had higher IAA and serum phosphorus but lower hemoglobin. The serum IAA concentration was positively correlated with both left ventricular mass (LVM) and left ventricular mass index (LVMI) but negatively correlated with both left ventricular ejection fraction (LVEF) and the ratio of left ventricular transmitral early peak flow velocity to left ventricular transmitral late peak flow velocity (E/A). Logistic regression analysis indicated that increased IAA levels are a risk factor for LVH and are not influenced by other factors. In addition, we exposed primary neonatal cultured mouse cardiomyocytes to varying concentrations of IAA in a controlled environment. Cardiomyocyte hypertrophy was induced by IAA in a concentration-dependent manner.

Conclusion: Serum IAA is correlated with alterations in both the function and structure of the left ventricle. The serum IAA concentration is an independent risk factor for LVH. IAA may be a novel biomarker of LVH in hemodialysis patients.

背景:在血液透析患者中,左心室肥厚(LVH)是一种普遍的心脏异常现象。尿毒症患者体内的尿毒症毒素吲哚-3-乙酸(IAA)会升高,但血液透析患者体内的 IAA 与左心室肥厚之间的关系仍不确定。因此,本研究旨在探讨血液透析患者血液中 IAA 水平与 LVH 之间的相关性:选取 205 名接受血液透析的患者,将其分为两组,有 LVH 的患者(143 人)和无 LVH 的患者(62 人)。收集患者的临床数据,并测量血清肌酐、钙、磷、血红蛋白和 IAA 水平:结果:与非 LVH 组相比,LVH 组的 IAA 和血清磷较高,但血红蛋白较低。血清IAA浓度与左心室质量(LVM)和左心室质量指数(LVMI)呈正相关,但与左心室射血分数(LVEF)和左心室透壁早期峰值流速与左心室透壁晚期峰值流速之比(E/A)呈负相关。逻辑回归分析表明,IAA水平升高是导致左心室肥厚的危险因素,且不受其他因素的影响。此外,我们在受控环境中将原代新生培养小鼠心肌细胞暴露于不同浓度的 IAA。IAA以浓度依赖性方式诱导心肌细胞肥大:结论:血清IAA与左心室功能和结构的改变相关。结论:血清IAA与左心室功能和结构的改变相关,血清IAA浓度是左心室肥厚的独立危险因素。IAA可能是血液透析患者左心室肥厚的新型生物标志物。
{"title":"Correlation between indole-3-acetic acid and left ventricular hypertrophy in hemodialysis patients.","authors":"Zhihua Lu, Wei Su, Ping Fan, Jiangtao Zhu, Cheng Chen","doi":"10.5414/CN111299","DOIUrl":"10.5414/CN111299","url":null,"abstract":"<p><strong>Background: </strong>Among hemodialysis patients, left ventricular hypertrophy (LVH) is a prevalent cardiac abnormality. The uremic toxin indole-3-acetic acid (IAA) is elevated in uremia patients, but the connection between IAA and LVH in individuals undergoing hemodialysis remains uncertain. Hence, the objective of this research was to examine the correlation between blood IAA levels and LVH in individuals undergoing hemodialysis.</p><p><strong>Materials and methods: </strong>In total, 205 individuals undergoing hemodialysis were chosen and categorized into two groups, with (143 patients) and without LVH (62 patients). Patient clinical data were collected, and serum creatinine, calcium, phosphorus, hemoglobin, and IAA levels were measured.</p><p><strong>Results: </strong>Compared to the non-LVH group, the LVH group had higher IAA and serum phosphorus but lower hemoglobin. The serum IAA concentration was positively correlated with both left ventricular mass (LVM) and left ventricular mass index (LVMI) but negatively correlated with both left ventricular ejection fraction (LVEF) and the ratio of left ventricular transmitral early peak flow velocity to left ventricular transmitral late peak flow velocity (E/A). Logistic regression analysis indicated that increased IAA levels are a risk factor for LVH and are not influenced by other factors. In addition, we exposed primary neonatal cultured mouse cardiomyocytes to varying concentrations of IAA in a controlled environment. Cardiomyocyte hypertrophy was induced by IAA in a concentration-dependent manner.</p><p><strong>Conclusion: </strong>Serum IAA is correlated with alterations in both the function and structure of the left ventricle. The serum IAA concentration is an independent risk factor for LVH. IAA may be a novel biomarker of LVH in hemodialysis patients.</p>","PeriodicalId":10396,"journal":{"name":"Clinical nephrology","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142616147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinicopathological features and outcomes of PLA2R-related membranous nephropathy with renal glycosuria. 伴有肾糖尿的 PLA2R 相关膜性肾病的临床病理特征和预后。
IF 1.1 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-11-01 DOI: 10.5414/CN111362
Piao Zhang, Feng Xu, Xumeng Liu, Ziyun Hu, Dandan Liang, Shaoshan Liang, Xiaodong Zhu, Fan Yang, Caihong Zeng

Background: Membranous nephropathy (MN) is an immune complex-mediated disease. Massive proteinuria can lead to Fanconi syndrome, clinically manifesting as renal glycosuria. The prevalence and prognosis of M-type phospholipase A2 receptor (PLA2R)-related MN with renal glycosuria remain unknown.

Materials and methods: Patients diagnosed with PLA2R-related MN with renal glycosuria were reviewed, and the control group comprised patients with MN without renal glycosuria who were randomly selected at a ratio of 1 : 3.

Results: 50 patients diagnosed with PLA2R-related MN with renal glycosuria from January 2015 to January 2020 were included, with a prevalence of 2.3%. Compared with patients without renal glycosuria, those with renal glycosuria exhibited greater proteinuria, lower estimated glomerular filtration rate (eGFR), and higher use of diuretics, anticoagulants, antibiotics, traditional Chinese medicine, and tacrolimus within 3 months prior to renal biopsy (all p < 0.05). Histologically, patients with renal glycosuria exhibited more severe pathological stages, acute/chronic tubulointerstitial lesions, and tubulointerstitial inflammation (all p < 0.05). Of the 10 patients treated with rituximab (RTX), proteinuria remission was maintained in 6 (60%) patients, and urine glucose remission was achieved in 5 of these 6 patients (83.3%). Multivariate Cox regression analysis showed that renal glycosuria and age > 50 years were independent risk factors for end-stage renal disease (ESRD) or a 30% reduction in the eGFR in patients with PLA2R-related MN.

Conclusion: PLA2R-related MN patients with renal glycosuria presented with more severe clinicopathological manifestations and worse prognoses. Nephrotoxic drugs should be administered rationally, and RTX should be considered as a promising treatment option.

背景:膜性肾病(MN)是一种由免疫复合物介导的疾病:膜性肾病(MN)是一种免疫复合物介导的疾病。大量蛋白尿可导致范可尼综合征,临床表现为肾糖尿。与 M 型磷脂酶 A2 受体(PLA2R)相关的肾性糖尿 MN 的发病率和预后仍不清楚:回顾性分析被诊断为PLA2R相关MN并伴有肾性糖尿的患者,对照组由随机抽取的不伴有肾性糖尿的MN患者组成,比例为1:3:结果:纳入了 50 名在 2015 年 1 月至 2020 年 1 月期间确诊为 PLA2R 相关 MN 并伴有肾性糖尿的患者,发病率为 2.3%。与无肾性糖尿的患者相比,有肾性糖尿的患者蛋白尿更多,估计肾小球滤过率(eGFR)更低,肾活检前3个月内使用利尿剂、抗凝剂、抗生素、中药和他克莫司的比例更高(均为50%),这些都是PLA2R相关MN患者发生终末期肾病(ESRD)或eGFR降低30%的独立危险因素:结论:伴有肾糖尿的 PLA2R 相关 MN 患者临床病理表现更严重,预后更差。应合理使用肾毒性药物,并将 RTX 作为一种有前景的治疗方案。
{"title":"Clinicopathological features and outcomes of PLA2R-related membranous nephropathy with renal glycosuria.","authors":"Piao Zhang, Feng Xu, Xumeng Liu, Ziyun Hu, Dandan Liang, Shaoshan Liang, Xiaodong Zhu, Fan Yang, Caihong Zeng","doi":"10.5414/CN111362","DOIUrl":"10.5414/CN111362","url":null,"abstract":"<p><strong>Background: </strong>Membranous nephropathy (MN) is an immune complex-mediated disease. Massive proteinuria can lead to Fanconi syndrome, clinically manifesting as renal glycosuria. The prevalence and prognosis of M-type phospholipase A2 receptor (PLA2R)-related MN with renal glycosuria remain unknown.</p><p><strong>Materials and methods: </strong>Patients diagnosed with PLA2R-related MN with renal glycosuria were reviewed, and the control group comprised patients with MN without renal glycosuria who were randomly selected at a ratio of 1 : 3.</p><p><strong>Results: </strong>50 patients diagnosed with PLA2R-related MN with renal glycosuria from January 2015 to January 2020 were included, with a prevalence of 2.3%. Compared with patients without renal glycosuria, those with renal glycosuria exhibited greater proteinuria, lower estimated glomerular filtration rate (eGFR), and higher use of diuretics, anticoagulants, antibiotics, traditional Chinese medicine, and tacrolimus within 3 months prior to renal biopsy (all p < 0.05). Histologically, patients with renal glycosuria exhibited more severe pathological stages, acute/chronic tubulointerstitial lesions, and tubulointerstitial inflammation (all p < 0.05). Of the 10 patients treated with rituximab (RTX), proteinuria remission was maintained in 6 (60%) patients, and urine glucose remission was achieved in 5 of these 6 patients (83.3%). Multivariate Cox regression analysis showed that renal glycosuria and age &gt; 50 years were independent risk factors for end-stage renal disease (ESRD) or a 30% reduction in the eGFR in patients with PLA2R-related MN.</p><p><strong>Conclusion: </strong>PLA2R-related MN patients with renal glycosuria presented with more severe clinicopathological manifestations and worse prognoses. Nephrotoxic drugs should be administered rationally, and RTX should be considered as a promising treatment option.</p>","PeriodicalId":10396,"journal":{"name":"Clinical nephrology","volume":" ","pages":"273-284"},"PeriodicalIF":1.1,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141888644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of the Omaha System nursing model on nutritional status outcomes in peritoneal dialysis patients. 奥马哈系统护理模式对腹膜透析患者营养状况的影响。
IF 1.1 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-11-01 DOI: 10.5414/CN111385
Cen Zhang, Ruo Zhuang, Xiao-Lei Chen, Xiao-Dong Cao, Meng-Ting Xue

Objective: To construct and apply a risk screening and intervention system for malnutrition in peritoneal dialysis patients based on the Omaha System.

Materials and methods: A total of 75 peritoneal dialysis patients were randomly divided into control (38 cases) and intervention group (37 cases). The control group received routine operation training and health education, and the intervention group implemented a nutritional management plan based on the Omaha System. The modified quantitative subjective comprehensive nutritional scale (MQSGA) score, kidney disease dietary compliance attitude (RAAQ) and behavior (RABQ) score, body mass index (BMI), serum albumin (ALB), prealbumin (PA), and hemoglobin (Hb) were observed.

Results: Before intervention, there was no significant difference in these indicators between the two groups (p > 0.05). After 6 months, the MQSGA score in the intervention group was significantly lower than that in the control group (p < 0.05). RAAQ score and RABQ score in the intervention group were higher than those in the control group and (p < 0.05), and the nutritional indicators in the intervention group, such as BMI, ALB, PA, and Hb, were higher than those in the control group (p < 0.05).

Conclusion: A nutritional management plan based on the Omaha System can help improve the nutrition condition of peritoneal dialysis patients, and improve the dietary compliance of chronic kidney disease patients.

目的:根据奥马哈系统构建并应用腹膜透析患者营养不良风险筛查和干预系统:以奥马哈系统为基础,构建并应用腹膜透析患者营养不良风险筛查和干预系统:将 75 例腹膜透析患者随机分为对照组(38 例)和干预组(37 例)。对照组接受常规操作培训和健康教育,干预组实施基于奥马哈系统的营养管理计划。观察改良定量主观综合营养量表(MQSGA)评分、肾病饮食依从性态度(RAAQ)和行为(RABQ)评分、体重指数(BMI)、血清白蛋白(ALB)、前白蛋白(PA)和血红蛋白(Hb):结果:干预前,两组患者的上述指标无明显差异(P>0.05)。6 个月后,干预组的 MQSGA 评分明显低于对照组(P 结论:干预组的 MQSGA 评分明显高于对照组(P基于奥马哈系统的营养管理计划有助于改善腹膜透析患者的营养状况,提高慢性肾病患者的饮食依从性。
{"title":"Use of the Omaha System nursing model on nutritional status outcomes in peritoneal dialysis patients.","authors":"Cen Zhang, Ruo Zhuang, Xiao-Lei Chen, Xiao-Dong Cao, Meng-Ting Xue","doi":"10.5414/CN111385","DOIUrl":"10.5414/CN111385","url":null,"abstract":"<p><strong>Objective: </strong>To construct and apply a risk screening and intervention system for malnutrition in peritoneal dialysis patients based on the Omaha System.</p><p><strong>Materials and methods: </strong>A total of 75 peritoneal dialysis patients were randomly divided into control (38 cases) and intervention group (37 cases). The control group received routine operation training and health education, and the intervention group implemented a nutritional management plan based on the Omaha System. The modified quantitative subjective comprehensive nutritional scale (MQSGA) score, kidney disease dietary compliance attitude (RAAQ) and behavior (RABQ) score, body mass index (BMI), serum albumin (ALB), prealbumin (PA), and hemoglobin (Hb) were observed.</p><p><strong>Results: </strong>Before intervention, there was no significant difference in these indicators between the two groups (p > 0.05). After 6 months, the MQSGA score in the intervention group was significantly lower than that in the control group (p < 0.05). RAAQ score and RABQ score in the intervention group were higher than those in the control group and (p < 0.05), and the nutritional indicators in the intervention group, such as BMI, ALB, PA, and Hb, were higher than those in the control group (p < 0.05).</p><p><strong>Conclusion: </strong>A nutritional management plan based on the Omaha System can help improve the nutrition condition of peritoneal dialysis patients, and improve the dietary compliance of chronic kidney disease patients.</p>","PeriodicalId":10396,"journal":{"name":"Clinical nephrology","volume":" ","pages":"264-272"},"PeriodicalIF":1.1,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142281354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of the efficacy of educational materials for chronic kidney disease during outpatient waiting time. 门诊候诊期间慢性肾病教育材料的效果比较。
IF 1.1 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-11-01 DOI: 10.5414/CN111413
Maiko Kimura, Daisuke Honda, Mizuyo Okura, Yuki Shiko, Yohei Kawasaki, Masashi Aizawa, Katsuhiko Asanuma

Aim: Patient education is crucial for preventing chronic kidney disease (CKD) progression, but adequate educational time is not always available in standard nephrology outpatient clinics. However, usefulness of educational materials provided by healthcare providers in educational settings has been reported. This study aimed to compare the efficacy of pamphlet and video materials in increasing CKD knowledge at a nephrology clinic using waiting time.

Materials and methods: 44 CKD stage 3 - 5 patients were randomly assigned to either pamphlet or video education group, receiving a single session during an outpatient visit. We evaluated the objective CKD knowledge score, perceived kidney disease knowledge score, self-care scores, and amount of estimated salt intake before and after the educational intervention.

Results: In both groups, the educational intervention significantly increased objective and perceived CKD knowledge scores (p < 0.001). No significant differences in increase in total knowledge scores between both groups were observed; however, different educational effects were observed in several individual knowledge items such as urinary protein and CKD stages. In both groups, self-care scores and amount of estimated salt intake did not change significantly before and after the intervention, but amount of estimated salt intake significantly decreased in patients with a history of dietary guidance (p = 0.044).

Conclusion: A single educational session with simple materials during outpatient waiting time at the nephrology clinic visit significantly improved patients' CKD knowledge, and suitable educational methods may differ according to knowledge items. Furthermore, patients who receive dietary guidance with specific instructions might exhibit salt reduction behavior through the use of educational materials.

目的:患者教育对预防慢性肾脏病(CKD)进展至关重要,但标准的肾脏病门诊并不总能提供充足的教育时间。不过,有报道称医疗服务提供者在教育环境中提供的教育材料非常有用。本研究旨在比较小册子和视频材料在肾科门诊利用候诊时间增加慢性肾脏病知识的效果。材料和方法:44 名慢性肾脏病 3-5 期患者被随机分配到小册子或视频教育组,在门诊就诊期间接受一次教育。我们评估了教育干预前后的客观肾脏病知识得分、感知肾脏病知识得分、自我护理得分以及估计的盐摄入量:在两组中,教育干预都显著提高了客观的肾脏病知识得分和感知的肾脏病知识得分(P < 0.001)。两组在知识总分的增加上无明显差异;但在尿蛋白和 CKD 分期等几个单项知识上,观察到了不同的教育效果。在干预前后,两组患者的自我护理得分和盐的估计摄入量没有明显变化,但有饮食指导史的患者盐的估计摄入量明显减少(p = 0.044):结论:在肾内科门诊候诊时间进行一次简单材料的教育可显著提高患者的慢性肾脏病知识水平,不同知识项目适合的教育方法可能不同。此外,接受有具体说明的饮食指导的患者可能会通过使用教育材料表现出减盐行为。
{"title":"Comparison of the efficacy of educational materials for chronic kidney disease during outpatient waiting time.","authors":"Maiko Kimura, Daisuke Honda, Mizuyo Okura, Yuki Shiko, Yohei Kawasaki, Masashi Aizawa, Katsuhiko Asanuma","doi":"10.5414/CN111413","DOIUrl":"10.5414/CN111413","url":null,"abstract":"<p><strong>Aim: </strong>Patient education is crucial for preventing chronic kidney disease (CKD) progression, but adequate educational time is not always available in standard nephrology outpatient clinics. However, usefulness of educational materials provided by healthcare providers in educational settings has been reported. This study aimed to compare the efficacy of pamphlet and video materials in increasing CKD knowledge at a nephrology clinic using waiting time.</p><p><strong>Materials and methods: </strong>44 CKD stage 3 - 5 patients were randomly assigned to either pamphlet or video education group, receiving a single session during an outpatient visit. We evaluated the objective CKD knowledge score, perceived kidney disease knowledge score, self-care scores, and amount of estimated salt intake before and after the educational intervention.</p><p><strong>Results: </strong>In both groups, the educational intervention significantly increased objective and perceived CKD knowledge scores (p < 0.001). No significant differences in increase in total knowledge scores between both groups were observed; however, different educational effects were observed in several individual knowledge items such as urinary protein and CKD stages. In both groups, self-care scores and amount of estimated salt intake did not change significantly before and after the intervention, but amount of estimated salt intake significantly decreased in patients with a history of dietary guidance (p = 0.044).</p><p><strong>Conclusion: </strong>A single educational session with simple materials during outpatient waiting time at the nephrology clinic visit significantly improved patients' CKD knowledge, and suitable educational methods may differ according to knowledge items. Furthermore, patients who receive dietary guidance with specific instructions might exhibit salt reduction behavior through the use of educational materials.</p>","PeriodicalId":10396,"journal":{"name":"Clinical nephrology","volume":" ","pages":"285-294"},"PeriodicalIF":1.1,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142139501","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current use, training, and barriers in point-of-care ultrasound in nephrology: A national survey of VA medical centers. 肾内科护理点超声波的当前使用、培训和障碍:退伍军人医疗中心全国调查。
IF 1.1 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-11-01 DOI: 10.5414/CN111464
Kevin J Murray, Abhilash Koratala, Ariadna Perez-Sanchez, Terry Lund, Anthony Andrade, Steven M Gorbatkin, John M Duch, Sandipani Sandilya, Jorge Lamarche, Michael J Mader, Elizabeth K Haro, Nilam J Soni, Robert Nathanson

Background: Point-of-care ultrasound (POCUS) can improve diagnostic accuracy, reduce procedural complications and enhance physician-patient interactions in nephrology. Currently, there is limited knowledge about how practicing nephrologists are using POCUS.

Objective: This study aimed to characterize current POCUS use, training needs, and barriers to use among nephrology groups.

Materials and methods: A prospective observational study of all Veterans Affairs (VA) medical centers was conducted between August 2019 and March 2020 using a web-based survey sent to all chiefs of staff and nephrology specialty chiefs.

Results: Chiefs of staff (n = 130) and nephrology chiefs (n = 79) completed surveys on facility- and service-level POCUS use (response rates of 100% and 77%, respectively). Current diagnostic or procedural POCUS use was reported by 41% of nephrology groups, and the most common POCUS applications were central line insertion (28%) and assessment of urinary retention (23%), hydronephrosis (18%), volume status (15%), and bladder (14%). Lack of training was the most common barrier (72%), and most nephrology groups (65%) desired POCUS training. Limited access to ultrasound equipment and POCUS training were barriers reported by 54% and 18% of groups, respectively.

Conclusion: A minority of nephrology groups currently use common POCUS applications including evaluation of urinary retention, hydronephrosis, and volume status. The most common barriers to POCUS use in nephrology were lack of trained providers and ultrasound equipment. Investment in POCUS training and infrastructure is needed to expand and standardize POCUS use in nephrology.

背景:护理点超声检查(POCUS)可提高诊断准确性、减少手术并发症并加强肾脏病学领域的医患互动。目前,人们对肾内科医师如何使用 POCUS 的了解还很有限:本研究旨在了解肾脏内科医师目前使用 POCUS 的情况、培训需求以及使用障碍:在 2019 年 8 月至 2020 年 3 月期间,对所有退伍军人事务(VA)医疗中心进行了一项前瞻性观察研究,向所有参谋长和肾内科专科主任发送了一份网络调查:参谋长(n = 130)和肾内科主任(n = 79)完成了关于设施和服务层面 POCUS 使用情况的调查(回复率分别为 100% 和 77%)。41% 的肾内科小组报告了当前诊断性或程序性 POCUS 的使用情况,最常见的 POCUS 应用是中心管插入(28%)和尿潴留评估(23%)、肾积水(18%)、容量状态(15%)和膀胱(14%)。缺乏培训是最常见的障碍(72%),大多数肾病学组(65%)希望获得 POCUS 培训。分别有 54% 和 18% 的小组报告称,超声设备和 POCUS 培训的获取受到限制:结论:少数肾脏病学组目前使用常见的 POCUS 应用,包括评估尿潴留、肾积水和容量状态。肾内科使用 POCUS 的最常见障碍是缺乏训练有素的医疗人员和超声设备。需要对 POCUS 培训和基础设施进行投资,以扩大 POCUS 在肾内科的应用并使其标准化。
{"title":"Current use, training, and barriers in point-of-care ultrasound in nephrology: A national survey of VA medical centers.","authors":"Kevin J Murray, Abhilash Koratala, Ariadna Perez-Sanchez, Terry Lund, Anthony Andrade, Steven M Gorbatkin, John M Duch, Sandipani Sandilya, Jorge Lamarche, Michael J Mader, Elizabeth K Haro, Nilam J Soni, Robert Nathanson","doi":"10.5414/CN111464","DOIUrl":"10.5414/CN111464","url":null,"abstract":"<p><strong>Background: </strong>Point-of-care ultrasound (POCUS) can improve diagnostic accuracy, reduce procedural complications and enhance physician-patient interactions in nephrology. Currently, there is limited knowledge about how practicing nephrologists are using POCUS.</p><p><strong>Objective: </strong>This study aimed to characterize current POCUS use, training needs, and barriers to use among nephrology groups.</p><p><strong>Materials and methods: </strong>A prospective observational study of all Veterans Affairs (VA) medical centers was conducted between August 2019 and March 2020 using a web-based survey sent to all chiefs of staff and nephrology specialty chiefs.</p><p><strong>Results: </strong>Chiefs of staff (n = 130) and nephrology chiefs (n = 79) completed surveys on facility- and service-level POCUS use (response rates of 100% and 77%, respectively). Current diagnostic or procedural POCUS use was reported by 41% of nephrology groups, and the most common POCUS applications were central line insertion (28%) and assessment of urinary retention (23%), hydronephrosis (18%), volume status (15%), and bladder (14%). Lack of training was the most common barrier (72%), and most nephrology groups (65%) desired POCUS training. Limited access to ultrasound equipment and POCUS training were barriers reported by 54% and 18% of groups, respectively.</p><p><strong>Conclusion: </strong>A minority of nephrology groups currently use common POCUS applications including evaluation of urinary retention, hydronephrosis, and volume status. The most common barriers to POCUS use in nephrology were lack of trained providers and ultrasound equipment. Investment in POCUS training and infrastructure is needed to expand and standardize POCUS use in nephrology.</p>","PeriodicalId":10396,"journal":{"name":"Clinical nephrology","volume":" ","pages":"257-263"},"PeriodicalIF":1.1,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141906113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical nephrology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1